rADAMTS-13 (SHP655)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rADAMTS-13 (SHP655), covering 2022-12-01 to 2022-12-01. Get the full timeline:
Most recent: Clinical Trial Update: Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) [Phase 2]